Approach to resectable gastric cancer: Evolving paradigm of neoadjuvant and adjuvant treatment Review

  


Authors: Lumish, M. A.; Ku, G. Y.
Review Title: Approach to resectable gastric cancer: Evolving paradigm of neoadjuvant and adjuvant treatment
Abstract: Recent therapeutic advances have prolonged survival in patients with metastatic gastric cancer, though the prognosis for patients with locally advanced resectable gastric cancer remains poor. Long-term survival after resection of locally advanced gastric adenocarcinoma is dependent on early eradication of micrometastatic disease and optimal surgical resection. Preoperative therapy with a docetaxel-containing three-drug regimen has recently been shown to be superior to an anthracycline-containing three-drug regimen or two-drug therapy with a fluoropyrimidine and platinum. Chemoradiation is not essential and is reserved for patients with suboptimal resection. Emerging research strategies include introduction of pre- and postoperative checkpoint blockade and biomarker-directed therapy. © 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Keywords: cancer surgery; postoperative period; cancer adjuvant therapy; chemotherapy, adjuvant; neoadjuvant therapy; positron emission tomography; antineoplastic agent; adenocarcinoma; antineoplastic combined chemotherapy protocols; practice guideline; pathology; patient care; preoperative period; adjuvant chemotherapy; stomach cancer; neoadjuvant chemotherapy; stomach neoplasms; chemoradiation; stomach tumor; gastric cancer; molecularly targeted therapy; perioperative therapy; immune checkpoint inhibitor; adjuvant chemoradiotherapy; chemoradiotherapy, adjuvant; humans; human; article; circulating tumor dna; immune checkpoint inhibition
Journal Title: Current Treatment Options in Oncology
Volume: 23
Issue: 7
ISSN: 1527-2729
Publisher: Springer  
Date Published: 2022-07-01
Start Page: 1044
End Page: 1058
Language: English
DOI: 10.1007/s11864-021-00917-1
PUBMED: 35524838
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130026656&doi=10.1007%2fs11864-021-00917-1&partnerID=40&md5=e502c6bedfcd60241497d50a997e713e
Notes: Article -- Export Date: 1 July 2022 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Geoffrey Yuyat Ku
    238 Ku
  2. Melissa Amy Lumish
    39 Lumish
Related MSK Work